Tower Research Capital LLC (TRC) - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 17 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,704
-64.0%
3,761
-39.7%
0.00%
-100.0%
Q2 2023$26,957
+299422.2%
6,240
+4.2%
0.00%
Q1 2023$9
+50.0%
5,986
+62.5%
0.00%
Q4 2022$6
-99.4%
3,684
+276.7%
0.00%
Q3 2022$1,000
-83.3%
978
-64.7%
0.00%
Q2 2022$6,000
+20.0%
2,770
+66.1%
0.00%
Q1 2022$5,000
-85.7%
1,668
-82.2%
0.00%
-100.0%
Q4 2021$35,000
+483.3%
9,360
+536.7%
0.00%
Q3 2021$6,000
-72.7%
1,470
-70.3%
0.00%
-100.0%
Q2 2021$22,000
+175.0%
4,949
+443.8%
0.00%
Q1 2021$8,000
+33.3%
910
-34.2%
0.00%
Q3 2020$6,0001,383
+1847.9%
0.00%
Q1 2019$0710.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders